We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
James Januzzi

James L Januzzi MD

Physician, Cardiology Division, Massachusetts General Hospital, Hutter Family Professor of Medicine, Harvard Medical School, Boston, MA

Dr. James Januzzi is a Physician in the Cardiology Division at the Massachusetts General Hospital and Hutter Family Professor of Medicine at the Harvard Medical School; he also serves as a Trustee for the American College of Cardiology, where he recently participated on the writing committee for an Expert Consensus Decision Pathway Document for novel diabetes drugs in cardiovascular diseases, endorsed by the American Diabetes Association.  He is a clinical trialist, on faculty at the Baim Institute for Clinical Research, and has published more than 500 peer reviewed manuscripts, reviews and book chapters in cardiology.  He has served as principal investigator on numerous trials of therapies for heart failure and has been a part of numerous committees for recent cardiovascular outcomes trials in therapies for diabetes.  He is presently on the steering committees for the EMPEROR-preserved and EMPEROR-reduced studies of empagliflozin in patients with heart failure.

Disclosures

Dr. Januzzi reported no relevant disclosures.